Delayed Renal Excretion of Methotrexate After a Severe Anaphylactic Reaction to Methotrexate in a Child With Osteosarcoma

dc.contributor.authorOzguven, AA
dc.contributor.authorUysal, K
dc.contributor.authorGunes, D
dc.contributor.authorKoroglu, T
dc.contributor.authorGurcu, O
dc.contributor.authorOlgun, N
dc.date.accessioned2025-04-10T10:32:51Z
dc.date.available2025-04-10T10:32:51Z
dc.description.abstractAlthough methotrexate is an agent widely used in the practice of pediatric oncology, allergic reactions to methotrexate are most unusual. Most of these reactions typically occur after repeated administration. Here, we report it severe anaphylactoid reaction to the first close of high-dose methotrexate infusion in a child with osteosarcoma who has also experienced it delayed excretion of methotrexate. Clinicians must be aware of the possibility of a systemic, near-fatal anaphylactic reactions with methotrexate and patients who experience severe anaphylactic reactions should be followed carefully because of the possibility of delayed methotrexate excretion.
dc.identifier.issn1077-4114
dc.identifier.urihttp://hdl.handle.net/20.500.14701/39174
dc.language.isoEnglish
dc.titleDelayed Renal Excretion of Methotrexate After a Severe Anaphylactic Reaction to Methotrexate in a Child With Osteosarcoma
dc.typeArticle

Files